Genovis strengthens its marketing organization in the US
Genovis has hired Kevin Cook as Senior Application & Market Area Manager for the subsidiary Genovis Inc. Kevin Cook has 20 years of experience with mass spectrometry from both the pharmaceutical and technology industries. Over the past ten years Kevin has worked with marketing and sales of instruments, consumables and reagents for mass spectrometry, which is a good fit with the market for Genovis’ products.
“I am extremely pleased that Kevin has chosen to work with Genovis and our growing team of talented and innovative employees. Kevin will contribute his extensive experience, unique expertise, and a large network developed through years in the industry. He will continue our efforts to strengthen Genovis’ business model based on a deep technical understanding of customer needs, which will further strengthen our brand and innovative impact,” said Fredrik Olsson, CEO of Genovis.
“I am excited to join such a technology-oriented company as Genovis, with its superior products,” said Kevin Cook.
For more information, please contact: Fredrik Olsson, CEO, Genovis AB Tel: 0046 (0)46 -101233 fredrik.olsson@genovis.com
ABOUT GENOVIS
Genovis’ business concept is to apply its knowledge and imagination to design and provide innovative tools for the development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes all over the world in innovative product formats that facilitate development and quality control of biological drugs.
The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (USA). Genovis shares are listed on Nasdaq First North Stockholm and Erik Penser Bank is the Company’s Certified Adviser. T: +46 (0)8-463 83 00.
This information is information that Genovis AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the contact person set out above, on April 24, 2018.
This press release is a translation of the Swedish original. In the event of any discrepancy between this translation and the Swedish original, the Swedish version shall prevail.